Wire Stories
PeptiDream Announces New Research and Collaboration Agreement with Lilly for the Discovery of Novel Peptide Drug Conjugates
KANAGAWA, Japan–(BUSINESS WIRE)–#Lilly–PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter �PeptiDream�)(Tokyo: 4587) today announced that they have...